» Articles » PMID: 19943124

Adverse Stress, Hippocampal Networks, and Alzheimer's Disease

Overview
Specialty Biochemistry
Date 2009 Nov 28
PMID 19943124
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Recent clinical data have implicated chronic adverse stress as a potential risk factor in the development of Alzheimer's disease (AD) and data also suggest that normal, physiological stress responses may be impaired in AD. It is possible that pathology associated with AD causes aberrant responses to chronic stress, due to potential alterations in the hypothalamic-pituitary-adrenal (HPA) axis. Recent study in rodent models of AD suggests that chronic adverse stress exacerbates the cognitive deficits and hippocampal pathology that are present in the AD brain. This review summarizes recent findings obtained in experimental AD models regarding the influence of chronic adverse stress on the underlying cellular and molecular disease processes including the potential role of glucocorticoids. Emerging findings suggest that both AD and chronic adverse stress affect hippocampal neural networks in a similar fashion. We describe alterations in hippocampal plasticity, which occur in both chronic stress and AD including dendritic remodeling, neurogenesis, and long-term potentiation. Finally, we outline potential roles for oxidative stress and neurotrophic factor signaling as the key determinants of the impact of chronic stress on the plasticity of neural networks and AD pathogenesis.

Citing Articles

"Methyl jasmonate: bridging plant defense mechanisms and human therapeutics".

Sharma G, Badruddeen , Akhtar J, Khan M, Ahmad M, Sharma P Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39847055 DOI: 10.1007/s00210-024-03752-x.


Prevalence and Incidence of Dementia in Patients With Non-Overtly Functional Adrenal Tumours.

Mirzaei H, Patrova J, Mannheimer B, Lindh J, Falhammar H Clin Endocrinol (Oxf). 2024; 102(4):371-379.

PMID: 39722568 PMC: 11874157. DOI: 10.1111/cen.15186.


Conceptual Framework for African American Kinship Caregiver's Susceptibility to Alzheimer's Disease.

Washington T, Coley S, Blakey J, Downing K, Wallace Q, Levkoff S Healthcare (Basel). 2024; 12(23.

PMID: 39685001 PMC: 11641078. DOI: 10.3390/healthcare12232379.


The Interplay of Stress, Inflammation, and Metabolic Factors in the Course of Parkinson's Disease.

Ben Shaul T, Frenkel D, Gurevich T Int J Mol Sci. 2024; 25(22).

PMID: 39596474 PMC: 11594997. DOI: 10.3390/ijms252212409.


Marital dissolution and cognition: The mediating effect of Aβ neuropathology.

Chandra A, Anjum R, Waters S, Proitsi P, Smith L, Marshall C Alzheimers Dement (Amst). 2024; 16(4):e70032.

PMID: 39473984 PMC: 11520438. DOI: 10.1002/dad2.70032.


References
1.
Shors T, Seib T, Levine S, Thompson R . Inescapable versus escapable shock modulates long-term potentiation in the rat hippocampus. Science. 1989; 244(4901):224-6. DOI: 10.1126/science.2704997. View

2.
Mattson M, Duan W, Wan R, Guo Z . Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulations. NeuroRx. 2005; 1(1):111-6. PMC: 534916. DOI: 10.1602/neurorx.1.1.111. View

3.
Sullivan P, Geiger J, Mattson M, Scheff S . Dietary supplement creatine protects against traumatic brain injury. Ann Neurol. 2000; 48(5):723-9. View

4.
Czeh B, Welt T, Fischer A, Erhardt A, Schmitt W, Muller M . Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis. Biol Psychiatry. 2002; 52(11):1057-65. DOI: 10.1016/s0006-3223(02)01457-9. View

5.
Mark R, Pang Z, Geddes J, Uchida K, Mattson M . Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci. 1997; 17(3):1046-54. PMC: 6573165. View